143 related articles for article (PubMed ID: 28626197)
1. Evaluation of CYP2D6 Protein Expression and Activity in the Small Intestine to Determine Its Metabolic Capability in the Japanese Population.
Kawakami M; Takenoshita-Nakaya S; Takeba Y; Nishimura Y; Oda M; Watanabe M; Ohta Y; Kobayashi S; Ohtsubo T; Kobayashi S; Uchida N; Matsumoto N
Biol Pharm Bull; 2017 Sep; 40(9):1344-1351. PubMed ID: 28626197
[TBL] [Abstract][Full Text] [Related]
2. Characterization of (+/-)-bufuralol hydroxylation activities in liver microsomes of Japanese and Caucasian subjects genotyped for CYP2D6.
Shimada T; Tsumura F; Yamazaki H; Guengerich FP; Inoue K
Pharmacogenetics; 2001 Mar; 11(2):143-56. PubMed ID: 11266079
[TBL] [Abstract][Full Text] [Related]
3. Individual metabolic capacity evaluation of cytochrome P450 2C19 by protein and activity in the small intestinal mucosa of Japanese pancreatoduodenectomy patients.
Hayashi M; Matsumoto N; Takenoshita-Nakaya S; Takeba Y; Watanabe M; Kumai T; Takagi M; Tanaka M; Otsubo T; Kobayashi S
Biol Pharm Bull; 2011; 34(1):71-6. PubMed ID: 21212520
[TBL] [Abstract][Full Text] [Related]
4. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes.
Kubota T; Yamaura Y; Ohkawa N; Hara H; Chiba K
Br J Clin Pharmacol; 2000 Jul; 50(1):31-4. PubMed ID: 10886115
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen.
Okishiro M; Taguchi T; Jin Kim S; Shimazu K; Tamaki Y; Noguchi S
Cancer; 2009 Mar; 115(5):952-61. PubMed ID: 19156902
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.
Veiga MI; Asimus S; Ferreira PE; Martins JP; Cavaco I; Ribeiro V; Hai TN; Petzold MG; Björkman A; Ashton M; Gil JP
Eur J Clin Pharmacol; 2009 Apr; 65(4):355-63. PubMed ID: 18979093
[TBL] [Abstract][Full Text] [Related]
7. Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients.
Okubo M; Murayama N; Miura J; Chiba Y; Yamazaki H
Biochem Pharmacol; 2015 Jan; 93(1):104-9. PubMed ID: 25475885
[TBL] [Abstract][Full Text] [Related]
8. Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population.
Céspedes-Garro C; Rodrigues-Soares F; Jiménez-Arce G; Naranjo MG; Tarazona-Santos E; Fariñas H; Barrantes R; Llerena A;
Rev Biol Trop; 2016 Sep; 64(3):1067-76. PubMed ID: 29461783
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes.
Byeon JY; Kim YH; Lee CM; Kim SH; Chae WK; Jung EH; Choi CI; Jang CG; Lee SY; Bae JW; Lee YJ
Arch Pharm Res; 2018 Sep; 41(9):921-930. PubMed ID: 30191460
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of 17 CYP2D6 allelic variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57).
Sakuyama K; Sasaki T; Ujiie S; Obata K; Mizugaki M; Ishikawa M; Hiratsuka M
Drug Metab Dispos; 2008 Dec; 36(12):2460-7. PubMed ID: 18784265
[TBL] [Abstract][Full Text] [Related]
11. Frequent occurrence of CYP2D6*10 duplication allele in a Japanese population.
Mitsunaga Y; Kubota T; Ishiguro A; Yamada Y; Sasaki H; Chiba K; Iga T
Mutat Res; 2002 Aug; 505(1-2):83-5. PubMed ID: 12175908
[TBL] [Abstract][Full Text] [Related]
12. The role of CYP2C19 in the metabolism of (+/-) bufuralol, the prototypic substrate of CYP2D6.
Mankowski DC
Drug Metab Dispos; 1999 Sep; 27(9):1024-8. PubMed ID: 10460802
[TBL] [Abstract][Full Text] [Related]
13. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations.
Yin SJ; Ni YB; Wang SM; Wang X; Lou YQ; Zhang GL
J Clin Pharm Ther; 2012 Jun; 37(3):364-9. PubMed ID: 21913948
[TBL] [Abstract][Full Text] [Related]
14. Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation.
Carcillo JA; Adedoyin A; Burckart GJ; Frye RF; Venkataramanan R; Knoll C; Thummel K; Roskos L; Wilson JW; Sereika S; Romkes M; Bebia Z; Branch RA
Clin Pharmacol Ther; 2003 May; 73(5):456-67. PubMed ID: 12732845
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans.
Lee SJ; Lee SS; Jung HJ; Kim HS; Park SJ; Yeo CW; Shin JG
Drug Metab Dispos; 2009 Jul; 37(7):1464-70. PubMed ID: 19364831
[TBL] [Abstract][Full Text] [Related]
16. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations.
Zuo LJ; Guo T; Xia DY; Jia LH
Genet Test Mol Biomarkers; 2012 Feb; 16(2):102-8. PubMed ID: 22224559
[TBL] [Abstract][Full Text] [Related]
17. Diverse structures of chimeric CYP-REP7/6-containing CYP2D6 and a novel defective CYP2D6 haplotype harboring single-type *36 and CYP-REP7/6 in Japanese.
Soyama A; Saito Y; Ohno Y; Komamura K; Kamakura S; Kitakaze M; Tomoike H; Ozawa S; Sawada J
Drug Metab Pharmacokinet; 2006 Oct; 21(5):395-405. PubMed ID: 17072093
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of hepatocyte nuclear factor-4alpha influences human cytochrome P450 2D6 activity.
Lee SS; Cha EY; Jung HJ; Shon JH; Kim EY; Yeo CW; Shin JG
Hepatology; 2008 Aug; 48(2):635-45. PubMed ID: 18666237
[TBL] [Abstract][Full Text] [Related]
19. A new CYP2D6 allele with a nine base insertion in exon 9 in a Japanese population associated with poor metabolizer phenotype.
Yokoi T; Kosaka Y; Chida M; Chiba K; Nakamura H; Ishizaki T; Kinoshita M; Sato K; Gonzalez FJ; Kamataki T
Pharmacogenetics; 1996 Oct; 6(5):395-401. PubMed ID: 8946471
[TBL] [Abstract][Full Text] [Related]
20. In vitro functional assessment of 22 newly identified CYP2D6 allelic variants in the Chinese population.
Dai DP; Geng PW; Wang SH; Cai J; Hu LM; Nie JJ; Hu JH; Hu GX; Cai JP
Basic Clin Pharmacol Toxicol; 2015 Jul; 117(1):39-43. PubMed ID: 25469868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]